Study of Levofloxacin and Cefoperazone-Sulbactam Utilization Cost on Patients with Mild and Moderate Corona Virus Disease- 2019: Studi Biaya Penggunaan Antibiotik Levofloxacin dan Cefoperazone-Sulbactam pada Pasien Corona Virus Disease-2019 Derajat Ringan sampai Sedang. Pharmasci [Internet]. 2024 Jun. 27 [cited 2025 Oct. 25];9(1):59-63. Available from: https://ejournal.akfarsurabaya.ac.id/index.php/jps/article/view/316